Grujic Alan bought GTHP
August 21, 2025 · Form 4 insider transaction
Grujic Alan bought 200,000 shares of Guided Therapeutics, Inc., a transaction worth N/A. The trade was recorded as j and disclosed on an SEC Form 4.
Direction
Acquired (buy-side)
Shares
200,000
Price
N/A
Total value
N/A
InsiderGrujic Alan
RoleDirector
SecurityCommon Stock
Transaction codeJ: J
Transaction dateAugust 21, 2025
Filing dateSeptember 5, 2025
Shares owned after1,665,433
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On August 21, 2025, Mr. Grujic converted 50 shares of Series E preferred stock into 200,000 shares of common stock. The Series E preferred stock had a stated value of $1,000 and $0.25 conversion price.